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To replicate SNP associations with preterm birth (PTB, birth <37 completed weeks of gestation) 
and synthesise currently available evidence using meta-analysis. 
Methods: 
Spontaneous PTB cases and controls were selected from an existing cohort.  Candidate SNPs 
were taken from an existing genotype panel.  A systematic review was conducted for each SNP 
in the panel to determine suitability as a PTB candidate. Those with significant associations 
previously reported in Caucasians were selected for replication.  Candidate SNPs were already 
genotyped in cases and controls and clinical data accessed from state perinatal and cerebral palsy 
databases.  Association analysis was conducted between each SNP and PTB and meta-analysis 
conducted if there were ≥three studies in the literature. Maternal and fetal SNPs were considered 
as separate candidates. 
Results: 
A cohort of 170 cases and 583 controls was formed. Eight SNPs from the original panel of 
genotyped SNPs were selected as PTB candidates and replication based on systematic literature 
review results.  In our cohort, fetal Factor V Leiden (FVL) was significantly associated with PTB 
(OR 2.6, 95% CI 1.31-5.17) and meta-analysis confirmed this association (OR 2.71, 95% CI 
1.15-6.4).  
Conclusion: 




The prevalence of preterm birth (birth at less than 37 completed weeks of gestation) continues to 
rise around the world with current selected international estimates being 11.1% of all births 1.  
Preterm birth is associated with poor outcomes for infants in both short and long terms and is 
accompanied with increased health care cost 2, 3, 4.  A global health priority is to reduce the 
incidence of preterm birth 5.  
An extensive number of factors contributing to preterm birth have been investigated to date 6 
including infection and inflammation related pathways 7, obstetric risks such as cervical 
insufficiency 8, multiple gestation 9, maternal history of preterm delivery 10, maternal BMI 11 and 
genetic predisposition 12.   
Recurrence of preterm birth across generations and between siblings has lead to the investigation 
of specific genetic associations with preterm birth 12.  The growing number of SNP associations 
has been reviewed systematically in 2005 13 and more recently curated to form an online resource 
incorporating a meta-analysis component 14, 15.   Many of the associations reported to date lack 
replication and there is substantial variation between reports including mixed ethnicities, variable 
cohort sizes, differing genetic models applied and different definitions of preterm birth between 
studies.  
Commencing with an already recruited cohort and associated panel of cerebral palsy candidate 
SNPs already genotyped, our aim was to systematically review the literature examining each of 
these genotyped SNPs as a potential candidate for PTB.  Where significant associations had been 
reported to date, these SNPs were considered PTB candidates.  Replication of these PTB 
associations was then attempted in this new cohort and findings combined with those reported in 




From within the Australian Cerebral Palsy Research Study, 170 cases and 583 controls were 
identified for spontaneous preterm birth analysis.  Demographic details for these groups are 
shown in table 1.  Cases of spontaneous preterm birth included 116 children diagnosed with 
cerebral palsy. 
Systematic Review 
When systematically searching Pubmed and Embase databases for evidence of SNP association 
with preterm birth in Caucasians, 1,521 articles were identified (see appendices for selection). 
541 papers were removed as duplicates, leaving 980 papers for review of title and abstract.  The 
full text of 78 papers were reviewed and eight SNPs from our panel were selected as replication 
candidates (see table 2).  
SNP associations 
Fetal Factor V Leiden (FVL) was significantly associated with spontaneous preterm birth (see 
table 3; odds ratio 2.6, 95% CI 1.31-5.17, p=0.008).  In stratified analysis examining those 
children who had a diagnosis of cerebral palsy, significant associations were found for fetal FVL 
(odds ratio 2.65, 95% CI 1.24-5.56, p=0.02).  Further stratification of the control group showed 
similar results (Tables S4 and S5). 
Meta-analysis 
Meta-analysis was performed for five SNPs (see figure 1; fetal TNF-α 308, fetal TLR4, maternal 
IL-6, fetal FVL and fetal PGM).  With the exception of fetal TNF-α 308, all SNP associations 
  
showed statistical heterogeneity and random effects methods were used for meta-analysis.  Fetal 
FVL was positively associated (odds ratio 2.71, 95 % CI 1.15-6.40) with PTB. 
Discussion 
Our replication analysis supports the association of fetal FVL with preterm birth and meta-
analysis supports a positive association of fetal FVL. 
Replication analysis of fetal FVL associations with preterm birth were significant in the overall 
cohort and also in sub-analysis examining only cases with cerebral palsy (OR 2.69, 95% CI 1.22-
5.92, p=0.02).  Association was detected for cases specifically without cerebral palsy (OR 2.71, 
95% CI 0.87-8.45) however this was not significant (p=0.1), possibly due to the low number of 
individuals in this strata (n=42).    
Our meta-analysis association of fetal FVL with spontaneous preterm birth is based on data from 
1,690 cases and 3,324 controls.  These data are taken from four published studies (in addition to 
the analysis we report in this paper).  We detected statistical heterogeneity in these data, possibly 
indicating differences in case or control definitions between the papers included (e.g. Gopel et al. 
16
 define preterm birth as <35 weeks, Gibson et al. 17 and the present analysis use <37 weeks).  
We were unable to further refine our definition of preterm birth for this and other potential sub-
analyses due to the small number of studies included. 
FVL is a well characterised functional SNP contributing to thrombosis 18.  The association of 
fetal FVL with preterm birth that we report may indicate a causal relationship between 
thrombosis and preterm delivery.  Our association analysis did not include mechanistic 
investigations so we can only speculate that FVL may increase the likelihood of placental 
thrombus formation  19, a risk factor for preterm delivery  20. 
  
The strengths of the present study include a well refined group of candidate SNPs for replication.  
A larger number of SNPs could have been examined, but we were unable to justify the selection 
of further candidate SNPs based on the evidence available in the published literature.  The 
analyses we report are strictly replication, and as such do not require statistical correction for 
multiple testing which is only recommended in exploratory analyses 21, however chance 
significance may still explain our results.  Our analysis also integrates a meta-analysis 
component with our replication, providing further evidence from a much larger sample size. 
The weaknesses of this report include the limited number of SNPs genotyped in the original 
study.  The literature provides evidence supporting other SNPs as candidates for preterm birth 
(e.g. IL1RN) but we were unable to assess them in this study (resource limitations) 14, 15. It is 
possible that publication bias limited the number of SNPs we selected for replication. We also 
highlight that the proportion of cases diagnosed with cerebral palsy in a not typical of the wider 
preterm birth population.  We acknowledge this limitation and the inclusion of stratification by 
cerebral palsy diagnosis provides at least partial control for this potential confounder.  The 
majority of reports included in our meta-analysis did not report details cerebral palsy diagnosis 
preventing us from stratifying our meta-analysis in a similar way.  Also, our controls had 
exclusion criteria of hypertension during pregnancy and growth restriction which were present in 
a few cases and could confound the data.  Gestational age data were obtained from state perinatal 
databases which typically collect the “best clinical estimate” of gestational age.   This estimate 
includes data from ultrasound in nearly all cases but occasionally uses last menstrual period 
dating methods only and may possibly lead to inaccuracies in case or control allocation where 
birth was close to 37 weeks gestation. 
  
This study is limited to the Caucasian population and we acknowledge there are robust candidate 
SNPs for preterm birth that warrant replication in other ethnic groups.  We are unable to 
generalise the findings we report beyond Caucasians. 
Due to the low number of studies reported, meta-analysis was conducted for only 5/8 selected 
candidate SNPs, highlighting the need for more work in the area of SNP associations with 
preterm birth.   
Despite these limitations, our replication analysis and meta-analysis provide support for the 
positive association of fetal FVL with preterm delivery in Caucasians.  As in many meta-
analyses of gene associations, few candidate genes remain associated with the pathology 
investigated.  More sophisticated genetic technologies such as massively parallel sequencing 
may uncover genetic alterations that have a greater effect on preterm birth. 
Methods 
Initial cohort 
The Australian Cerebral Palsy Research Study cohort was used for this analysis.  The original 
study design is described in detail elsewhere  22. In summary, mother-child case and control pairs 
(one child per family) were recruited between July 2008 and March 2010 from around Australia 
with the following inclusion criteria: children were aged between 5 and 18 years, born in 
Australia and of Caucasian background. Cases in the initial cohort were defined as children with 
a diagnosis of cerebral palsy and controls were children without cerebral palsy. Five hundred and 
eighty-seven case families and 1,154 control families were recruited during the same time period 
and included in the analysis. Informed consent was obtained from all participants. 
  
Case selection 
Preterm birth cases used in this analysis were taken from the Australian Cerebral Palsy Research 
Study.  Preterm birth cases were selected as infants whose gestational age was less than 37 
weeks and who delivered spontaneously.  Cases included children with cerebral palsy and those 
without, with separate analysis conducted for each group. Multiple births were included. 
Control selection 
Controls were also selected from the Australian Cerebral Palsy Research Study.  Controls were 
required to be delivered spontaneously at greater than or equal to 37 weeks gestational age.  For 
the primary analysis, controls included individuals with and without cerebral palsy.  Individuals 
with maternal hypertension during pregnancy or growth restriction less than the 10th centile were 
excluded.  
Clinical data 
Clinical data including gestational age, maternal hypertension during pregnancy, birth weight 
and mode of delivery were provided by state perinatal databases.  Cerebral palsy diagnoses were 
provided by state cerebral palsy registers.  
Candidate SNP selection – Systematic Review 
Candidate SNPs were selected from those previously screened for association with cerebral palsy 
23
 (see Table S1). SNPs in the original cerebral palsy candidate panel were predominantly 
involved in regulation of coagulation and inflammation.  All SNPs in the cerebral palsy 
candidate panel were used in this study with fetal and maternal SNPs considered as separate 
candidates.  For each SNP, we conducted a systematic literature review, assessing the evidence 
for their association with preterm birth. The search strategy was developed by one author with 
  
assistance from a university research librarian and considered only full papers published in 
English. Papers up to December 2008 were retrieved from an already published online data base 
of associations 15. Relevant references within these papers were also selected.  Papers from 2008 
until June 2012 were searched using the same strategy (see supplementary material for details of 
search terms). Relevant references within these papers were also selected. For inclusion in our 
candidate panel, positive SNP associations must have been reported with PTB in at least one 
previous case-control study, and the reported study must have examined a Caucasian population.  
DNA samples were taken from a Caucasian population and we could therefore only attempt to 
replicate SNP associations that had previously been reported in Caucasians.  Guidelines for 
replication were taken from a published international consensus statement  21.   
Genotyping 
DNA samples were collected using buccal swabs.  SNP genotyping was performed by the 
Australian Genome Research Facility (AGRF, Brisbane Node, Brisbane, Australia) on a 
MassARRAY iPLEX Gold System (Sequenom, San Diego, CA).   
 Analysis 
SNP association testing 
Analysis was conducted using the package ‘SNPassoc’ in the R environment (R Foundation for 
Statistical Computing, Vienna, Austria) 24.  All association tests conducted are reported with 
odds ratio, 95% confidence intervals and p values.  Association tests were conducted using the 
genetic model originally reported for each candidate SNP.    SNPs were assessed for Hardy-
Weinberg equilibrium and genotype failure rate. Genotype counts for cases and controls are 
  
reported. Replication analyses followed international guidelines and did not include statistical 
correction for multiple testing  21. 
Meta-analysis 
Meta analysis was conducted where three or more associations had been reported (including this 
report) and was performed using Review Manager Software version 5.1 (The Nordic Cochrane 
Centre, The Cochrane Collaboration, Copenhagen, Denmark).  For each study included in the 
meta-analysis the number of cases and controls, minor and major allele counts, effect measures 
with confidence intervals and genetic models used was extracted.  Details for study quality 
assessment were also extracted for recommended checklists 25.  Fixed effects analysis was used 
where there was no evidence for heterogeneity (p>0.05, Chi squared test) and a random effects 
analysis used when heterogeneity was significant.  Forest plots were used to assess publication 
bias for each meta-analysis. 
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Figure 1.  Forest plots for meta-analysis of SNPs and preterm birth. 
M-H - Mantel-Haenszel 
a. TNF-α 308 and PTB 
b. TLR4 and PTB 
c. FVL and PTB 
d. Maternal IL-6 and PTB 
e. PGM and PTB 
black square – effect estimate and weight of each study 
black diamond – overall effect 
 
 
